Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kewaunee Scientific's annualized ROCE % for the quarter that ended in Apr. 2026 was 16.80%.
Kewaunee Scientific (FRA:KEW) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Kewaunee Scientific ROCE % Related Terms
Kewaunee Scientific ROCE % Historical Data
* Premium members only.
The historical data trend for Kewaunee Scientific's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kewaunee Scientific (FRA:KEW) has a ROCE % of 16.80% as of Apr. 2026.
Is Kewaunee Scientific's ROCE % too high?
Kewaunee Scientific's current ROCE % is 16.80%. The Furnishings, Fixtures & Appliances industry median ROCE % is 5.51. Kewaunee Scientific's value of 16.80% is 204.9% above this industry median. Overall, Kewaunee Scientific has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kewaunee Scientific's ROCE % compare to VIRC and BSET?
Kewaunee Scientific's ROCE % of 16.80% can be compared against companies in the Furnishings, Fixtures & Appliances industry. The industry median ROCE % is 5.51. Kewaunee Scientific's value of 16.80% is 204.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Furnishings, Fixtures & Appliances company?
The median ROCE % among Furnishings, Fixtures & Appliances companies is 5.51, based on 428 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kewaunee Scientific's current ROCE % of 16.80% is 204.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Furnishings, Fixtures & Appliances industry, the median ROCE % is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kewaunee Scientific's current ROCE % is 16.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kewaunee Scientific stock overvalued right now?
Based on GuruFocus' analysis, Kewaunee Scientific (FRA:KEW) is currently considered Modestly Undervalued. The stock's GF Value™ is €37.88, compared to a current price of €31.20 — trading 17.6% below its estimated fair value. The current ROCE % is 16.80% and 204.9% above the Furnishings, Fixtures & Appliances industry median of 5.51. Kewaunee Scientific's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Kewaunee Scientific (FRA:KEW), the current ROCE % is 16.80% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kewaunee Scientific (FRA:KEW) Overvalued in 2026?
Based on GuruFocus' analysis, Kewaunee Scientific stock appears to be undervalued.
The current stock price of €31.20 is trading 17.6% below its estimated GF Value™ of €37.88.
GuruFocus considers Kewaunee Scientific to be Modestly Undervalued.
Key valuation signals for FRA:KEW:
ROCE %: 16.80%
GF Value™: €37.88 vs. price of €31.20 (17.6% below fair value)
Industry Position: 204.9% above the Furnishings, Fixtures & Appliances median
No single metric tells the full story. See the FRA:KEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
72GF Score
Get the complete analysis for FRA:KEW
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:KEW has been successfully added to your 
